Clinical Trial Update: Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the safety and effectiveness of SGLT-2 inhibitors in patients with heart failure and diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: University of Dundee | Conditions: Heart Failure, Diabetes | Phase 4 | Status: COMPLETED